Phibro Animal Health earnings were $19.3M for the trailing 12 months ending Dec 31, 2024, with 29.7% growth year over year. The latest PAHC earnings report on Dec 31, 2024 announced Q4 2024 earnings of $3.2M, down 54.3% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, PAHC reported annual earnings of $2.4M, with -92.6% growth. The next PAHC earnings date is May 6, 2025.
PAHC past earnings growth
How has PAHC's earnings growth performed historically?
Phibro Animal Health Earnings Reports & History FAQ
What were Phibro Animal Health's earnings last quarter?
On PAHC's earnings call on Invalid Date, Phibro Animal Health (NASDAQ: PAHC) reported Q4 2024 earnings per share (EPS) of $0.08, up 166.67% year over year. Total PAHC earnings for the quarter were $3.19 million. In the same quarter last year, Phibro Animal Health's earnings per share (EPS) was $0.03.
The next PAHC earnings date is Invalid Date. Add PAHC to your watchlist to be reminded of Phibro Animal Health's next earnings date.
What was PAHC's earnings growth in the past year?
As of Phibro Animal Health's earnings date in Invalid Date, Phibro Animal Health's earnings has grown 29.73% year over year. This is 25.69 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.42%. PAHC earnings in the past year totalled $19.32 million.
Is Phibro Animal Health profitable or losing money?
As of the last Phibro Animal Health earnings report, Phibro Animal Health is currently profitable. Phibro Animal Health's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $19.32 million, a 30.53% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.